Concepedia

Dora M. Schnur

DM

Statistics

Publications

17

Citations

878

H-Index

15

Active since

1977

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Monsanto (United States)

Bristol-Myers Squibb (Sweden)

University of North Carolina at Chapel Hill

Dora M. Schnur is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1977–2017

17

Publications

17

EPSP Synthase: The Design and Synthesis of Bisubstrate Inhibitors Incorporating Novel 3-Phosphate Mimics

James A. Sikorski, Michael J. Miller, Diane S. Braccolino et al. · Phosphorus, sulfur, and silicon and the related elements · 1993 · 130 citations

, , +12

Antitumor agents. 113. New 4.beta.-arylamino derivatives of 4'-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II

Zhe Qing Wang, Yao Haur Kuo, Dora M. Schnur et al. · Journal of Medicinal Chemistry · 1990 · 107 citations

, , +8

Are Target-Family-Privileged Substructures Truly Privileged?

Dora M. Schnur, Mark A. Hermsmeier, Andrew J. Tebben · Journal of Medicinal Chemistry · 2006 · 101 citations

, , +17

2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors

James J. Li, Haixia Wang, Joseph A. Tino et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 92 citations · Full text

, , +8

Conformationally Constrained <i>ortho-</i>Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y<sub>1</sub> Antagonist

Jennifer X. Qiao, Tammy C. Wang, Réjean Ruel et al. · Journal of Medicinal Chemistry · 2013 · 70 citations · Full text

, , +17

1–5 of 17